Does childhood treatment of ADHD with stimulant medication affect substance abuse in adulthood?

American Journal of Psychiatry

Volumn 165, Issue 5, 2008, Pages 553-555

  Volkow, Nora D ^a   Swanson, James M ^b  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; METHYLPHENIDATE;

ATTENTION DEFICIT DISORDER; CLINICAL PRACTICE; DRUG ABUSE; DRUG DEPENDENCE; EDITORIAL; HIGH RISK PATIENT; HUMAN; LONG TERM CARE; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUBSTANCE ABUSE;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; FOLLOW-UP STUDIES; HUMANS; SUBSTANCE-RELATED DISORDERS;

EID: 43949133846     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.2008.08020237     Document Type: Editorial

References (14)

1. Wise RA: Brain reward circuitry: insights from unsensed incentives. Neuron 2002; 36:229-240
2. Volkow ND, Swanson JM: Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry 2003; 160:1909-1918
3. Grant BF, Dawson DA: Age at onset of alcohol use and its association with DSM-IV alcohol abuse and dependence: results from the National Longitudinal Alcohol Epidemiologic Survey. J Subst Abuse 1997; 9:103-110
4. Wilens TE, Faraone SV, Biederman J, Gunawardene S: Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 2003; 111:179-185
5. Elkins IJ, McGue M, Iacono WG: Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse. Arch Gen Psychiatry 2007; 64:1145-1152
6. Biederman J, Monuteaux MC, Spencer T, Wilens TE, MacPherson HA, Faraone SV: Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study. Am J Psychiatry 2008; 165:597-603
7. Mannuzza S, Klein RG, Truong NL, Moulton JL III, Roizen ER, Howell KH, Castellanos FX: Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood. Am J Psychiatry 2008; 165:604-609
8. Volkow ND, Insel TR: What are the long-term effects of methylphenidate treatment? Biol Psychiatry 2003; 54:1307-1309
9. Molina BS, Flory K, Hinshaw SP, Greiner AR, Arnold LE, Swanson JM, Hechtman L, Jensen PS, Vitiello B, Hoza B, Pelham WE, Elliott GR, Wells KC, Abikoff HB, Gibbons RD, Marcus S, Conners CK, Epstein JN, Greenhill LL, March JS, Newcorn JH, Severe JB, Wigal T: Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. J Am Acad Child Adolesc Psychiatry 2007; 46:1028-1040
10. Pelham WE: ADHD treatment with stimulant medication and later substance use, in Proceedings of the 51st Annual Meeting of the American Academy of Child and Adolescent Psychiatry. Washington, DC, AACAP, 2004
11. Costello EJ, Foley DL, Angold A: 10-year research update review: the epidemiology of child and adolescent psychiatric disorders, II: developmental epidemiology. J Am Acad Child Adolesc Psychiatry 2006; 45:8-25
12. Kessler RC, Adler LA, Barkley R, Biederman J, Conners CK, Faraone SV, Greenhill LL, Jaeger S, Secnik K, Spencer T, Ustün TB, Zaslavsky AM: Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the National Comorbidity Survey Replication. Biol Psychiatry 2005; 57:1442-1451
13. Volkow ND, Wang GJ, Newcorn J, Telang F, Solanto MV, Fowler JS, Logan J, Ma Y, Schulz K, Pradhan K, Wong C, Swanson JM: Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/ hyperactivity disorder. Arch Gen Psychiatry 2007; 64:932-940
14. Sonuga-Barke EJ: The dual pathway model of AD/HD: an elaboration of neuro-developmental characteristics. Neurosci Biobehav Rev 2003; 27:593-604